Other studies have shown that, as biomarkers of the severity of COVID-19 in pregnant women, the expression of IL-6 and IL-10 acts by minimizing or maximizing the risks of adverse outcomes, with the lowest expression of the cytokines related to asymptomatic cases and the high expression of severe symptoms [82]. The gene discussed is IL10; the disease is COVID-19.